6
Views
4
CrossRef citations to date
0
Altmetric
Original Article

P450 Metabolism in Fibromyalgia

, , , &
Pages 25-32 | Published online: 16 Jan 2010

References

  • Wolfe F, Ross K, Anderson J, Russell IJ: The prevalence and characteris-tics of fibromyalgia in the general population. Arthritis Rheum 38:19–28, 1995.
  • Forseth KO, Gran JT: The prevalence of fibromyalgia among women age 20-49 years in Arendal, Norway. Scand J Rheumatol 21:74–8, 1992.
  • Buskila D, Press J, Gedalia A, et al.: Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J Rheumatol 20:368–70, 1993.
  • Clauw DJ: Fibromyalgia: More than just a musculoskeletal disease. Am Fam Phys, in press.
  • Buchwald D, Garrity D: Comparison of patients with chronic fatigue syn-drome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 154: 2049–53, 1994.
  • Slotkoff AT, Radulovic DA, Clauw DJ: The relationship between multiple chemical hypersensitivity and fibromyalgia. Arthritis Rheum 37[9S]:1117, 1994.
  • Alvan G: Clinical consequences of polymorphic drug oxidation. Fundam Clin Phaimacol 5:209–228, 1991.
  • Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates J: Ef-fect of acetylator phenotype on the rate at which procainamide induces antinu-clear antibodies and the lupus syndrome. N Eng J Med 298:1157–1159, 1978.
  • May DG, Black CM, Olsen NJ, et al.: Scleroderma is associated with dif-ferences in individual routes of drug metabolism: a study with dapsone, debriso-quin, and mephenytoin. Clin Pharmacol Ther 48[3]:286-295, 1990.
  • Floc}chart DA, Clauw DJ, Sale EB, Hewett J, Woosley RL: Phanuacoge-netic characteristics of the Eosinophilia Myalgia Syndrome. Clin Pharm Ther 56: 398–405, 1994.
  • Buchert ET, Woosley RL, Swain SM, et al.: Relationship of CYP2D6 [de-brisoquin hydroxylase] genotype to breast cancer susceptibility. Pharmacogenet-ics 3:322-27, 1993.
  • Wedlund PJ, Sweetman PJ, McAllister CB, Branch RA, Wilkinson GR: Di-rect enantiomeric resolution of mephenytoin and its N-demethylatecl metabolite in plasma and blood using chiral gas chromatography. J Chromatogr 307:121–27, 1984.
  • Tybring G, Bertilsson L: A methodological investigation on the estimation of the S-mephenytoin hydroxylation phenotype using the urinary S/R ratio. Phar-macogenetics 2:241–3, 1992
  • Broly F, Gaedigk A, Heim M, et al.: Debrisoquin/sparteine hydroxylation genotype and phenotype. DNA Cell Biol 10:545–558, 1991.
  • Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheu-matology 1990 Criteria for the Classification of Fibromyalgia. Report of the Mul-ticenter Criteria Committee. Arthritis Rheum 33:160–172, 1990.
  • Goldenberg DL: Fibromyalgia, chronic fatigue, and myofascial pain syn-dromes. Curr Opin Rheumatol 4:247–57, 1992.
  • Yunus MB: Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation [editorial]. J Rheumatol 19:846–7, 1992.
  • Russell IJ, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35:550–56, 1992.
  • Okino ST, Quattrochi LC, Pendurthi UR, McBride OW, Tikey RH: Charac-terization of multiple cytochrome P450 cDNAs: the chromosomal localization of the gene and evidence for alternative RNA splicing. J Biol Chem 262:16072–79, 1987.
  • Gerster JC, Hadj-Djilani A: Hearing and vestibular abnormalities in prima-ry fibrositis syndrome. J Rheumatol 11:678, 1984.
  • Clauw DJ, Kay G, Potolicchio S, Starbuck V: Abnormal auditory event re-lated potentials in fibromyalgia. Arthritis Rheum 37[6S]:50, 1994.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.